Insulet (PODD) - 2022 Q4 - Earnings Call Transcript

Thanks, Deb. Good afternoon, and thank you for joining us. In Q4, the global Insulet team delivered another record quarter of growth, which was a strong end cap to a remarkable 2022. We exceeded our expectations once again, achieving revenue growth of 45% in the U.S. and over 35% for total Omnipod and our U.S. and global new customer starts were at record levels. And 2022 marked our seventh consecutive year of 20-plus percent Insulet Corporation (NASDAQ:PODD) Q4 2022 Results Conference Call February 23, 202 ...